Journal profile · BIOTECHNOLOGY & APPLIED MICROBIOLOGY-GENETICS & HEREDITY

Human Gene Therapy Methods

ISSN 1946-6536 · eISSN 1946-6544 · Mary Ann Liebert Inc. · UNITED STATES

Human Gene Therapy Methods: hybrid open access; review over 12 weeks (community reports); community-reported acceptance: easy; 0 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ1Applied Microbiology and Biotechnology · rank 28/113
Review timeover 12 weeksCommunity average
APC—No source gives fee information
AcceptanceEasyCommunity average
Articles per year02025 · OpenAlex count

Scope

Aims, scope and focus

Human Gene Therapy Methods is published by Mary Ann Liebert Inc.. By OpenAlex counts of its recent articles, its largest topics are Virus-based gene therapy research, RNA Interference and Gene Delivery and Viral Infectious Diseases and Gene Expression in Insects, together about 64.5% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases. The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.

Source: LetPub

Research area (LetPub): BIOTECHNOLOGY & APPLIED MICROBIOLOGY-GENETICS & HEREDITY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology33.3%
  2. RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology23.5%
  3. Viral Infectious Diseases and Gene Expression in InsectsBiochemistry, Genetics and Molecular Biology7.7%
  4. CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology4.2%
  5. Immunotherapy and Immune ResponsesImmunology and Microbiology3.4%
  6. CAR-T cell therapy researchMedicine2.5%
  7. Protein purification and stabilityBiochemistry, Genetics and Molecular Biology2.3%
  8. Neurogenetic and Muscular Disorders ResearchMedicine2.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
Applied Microbiology and BiotechnologyQ128/113—
PharmacologyQ282/297—
GeneticsQ2108/325—
Genetics (clinical)Q230/87—
Molecular MedicineQ269/167—

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
5.8LetPub ·
SJR 2026-06
0.92LetPub ·
SNIP 2026-06
0.9LetPub ·
h-index
20LetPub ·
h-index
47OpenAlex ·
i10-index
174OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
12.5%LetPub ·

Articles by year OpenAlex count · 272 in total · the current year is incomplete

YearArticlesOpen accessCitations
202600431
202500672
202400783
202300817
202200691
202100913

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Mary Ann Liebert Inc.
Country or region
UNITED STATES
Language
English
ISSN
1946-6536
Electronic ISSN
1946-6544
Official links

FAQ

Frequently asked questions about Human Gene Therapy Methods

How long does peer review take at Human Gene Therapy Methods?

Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Human Gene Therapy Methods?

According to LetPub and DOAJ records, Human Gene Therapy Methods is indexed in Scopus.

Is Human Gene Therapy Methods open access, and what is the APC?

Human Gene Therapy Methods is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .